Ki-67, S-100, Calretinine and Reticulin Profile of Adrenal Lesions and Their Correlations with Standard Histological Criteria

Authors

  • Sreejita Mridha Department of Pathology, Institute of Postgraduate Medical Education and Research, Kolkata, West Bengal, India
  • Debashis Chakrabarty Associate Professor, Department of Pathology, Institute of Postgraduate Medical Education and Research, Kolkata, West Bengal, India

DOI:

https://doi.org/10.37591/rrjoi.v9i2.1572

Abstract

Histological diagnosis of adrenal lesions is difficult and needs multiple approaches. Histopathological examinations of 31 adrenal specimens were categorized following Weiss and Pass method and scorings were done. Immunohistochemical and special stains were also performed. In the present study, the 12 medullary cases included pheochromocytoma, neuroblastoma, ganglioneuroma, metastasis to adrenal tissue and metstatic pheochromocytoma.19 cortical cases included cortical hyperplasia, adenomas, carcinomas, myelolipomas and one case of cortical carcinoma. Weiss score for cortical carcinoma was more than ‘3’. Pass scores of malignant medullary tumours were more than ‘4’. Immunohistochemical profile and special staining results matched well with the scoring system and histological diagnosis. Combination of gross and histopathological examination including special stain, Weiss and PASS scoring system and immunohistochemical profile help in proper diagnosis of adrenal lesions and should be followed as routine protocol.

 

Keywords: Histopathology, immunohistochemistry, Weiss and Pass score

Cite this Article

Sreejita Mridha, Debashis Chakrabarty. Ki-67, S-100, Calretinine and Reticulin Profile of Adrenal Lesions and Their Correlations with Standard Histological Criteria. Research & Reviews: A Journal of Immunology. 2019; 9(2): 30–35p.

Downloads

Published

2019-08-26

Issue

Vol. 9 No. 2 (2019)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.